Vista Klinik

Academic / Other · 7 registered clinical trials.

Status	Trial	Phase	Started
Unknown	Intravitreal Faricimab in Diabetic Macular Edema With Limited Response to Aflibercept Diabetic Macular Edema	Phase 4	2022-11-01
Terminated	Intravitreal Brolucizumab in Neovascular Age-related Macular Degeneration With Limited Response to Aflibercept Neovascular Age-related Macular Degeneration	Phase 4	2020-07-20
Completed	Intravitreal Aflibercept in Neovascular AMD With Limited Response to Ranibizumab Neovascular Age-related Macular Degeneration	Phase 4	2013-05-01
Completed	Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy Insulin-Dependent Diabetes Mellitus 1	—	2012-09-01
Completed	SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia Choroidal Neovascularization, Age Related Macular Degeneration	Phase 4	2011-06-01
Completed	Time Course of Activity Signs at SD-OCT High Frequency Intravitreal Ranibizumab Treatment in CNV Due to AMD Choroidal Neovascularization, Age Related Macular Degeneration	Phase 4	2010-12-01
Completed	Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy Insulin-Dependent Diabetes Mellitus 1	N/A	2010-08-01